Takeda Pharmaceutical Co., Ltd. (TAK)
18.68
+0.39
(+2.13%)
USD |
NYSE |
Apr 08, 13:38
Takeda Pharmaceutical EPS Diluted (Quarterly) : 0.2099 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | -1.203 |
| Protagonist Therapeutics, Inc. | -0.6932 |
| Eli Lilly & Co. | 7.024 |
| Sanofi | -- |
| Nxera Pharma Co., Ltd. | -0.5538 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 673.28M |
| Revenue (Quarterly) | 7.735B |
| Total Expenses (Quarterly) | 7.062B |
| Enterprise Value | 84.56B |
| Gross Profit Margin (Quarterly) | 54.43% |
| Profit Margin (Quarterly) | 8.70% |
| Earnings Yield | 1.28% |
| Operating Earnings Yield | 5.91% |
| Normalized Earnings Yield | 1.858 |